4//SEC Filing
Piper Brian 4
Accession 0001192482-18-000302
CIK 0001138776other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:25 PM ET
Size
6.1 KB
Accession
0001192482-18-000302
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2018-06-14+238,000→ 238,000 totalExercise: $1.55Exp: 2028-04-17→ Common Stock (238,000 underlying)
Footnotes (2)
- [F1]The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018.
- [F2]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on April 17, 2019, then in 24 equal monthly installments on the 17th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.
Documents
Issuer
Aevi Genomic Medicine, Inc.
CIK 0001138776
Entity typeother
Related Parties
1- filerCIK 0001665924
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:25 PM ET
- Size
- 6.1 KB